Royalty Pharma plc (RPRX) Operating margin 2018–2025
Royalty Pharma plc (RPRX) operating margin by fiscal year — reported operating income divided by reported revenue.
65.6%FY2025 · since FY2018: 76.0% → 65.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 65.6% | +8.5 pp |
| FY2024 | 57.1% | -6.3 pp |
| FY2023 | 63.4% | +49.6 pp |
| FY2022 | 13.7% | -48.8 pp |
| FY2021 | 62.5% | -12.7 pp |
| FY2020 | 75.2% | -69.4 pp |
| FY2019 | 144.6% | +68.6 pp |
| FY2018 | 76.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice